YY

Yue Yang

Senior Director, Computational Chemistry at BridgeBio Oncology Therapeutics (BBOT)

Yue Yang is a highly experienced professional in the field of computational chemistry, currently serving as Senior Director at BridgeBio Oncology Therapeutics since November 2024. Prior to this role, Yue Yang worked at Lawrence Livermore National Laboratory as a Staff Scientist and Principal Investigator, focusing on oncology drug discovery and leading projects such as the development of dual inhibitors and a drug discovery platform enhanced by machine learning. With earlier positions as a Computational Chemist at ATOM and a Postdoctoral Scientist involved in antibiotic discovery, Yue Yang has extensive research background in various aspects of chemistry, including transition metal complexes and photochemistry. Academic credentials include a PhD in Computational Chemistry from the University of Florida and a BS in Chemical Physics from the University of Science and Technology of China.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.